Therapeutics Ap S Alteral Ekimas Corp (ASNB) insider trading activity
Therapeutics Ap S Alteral is > 10% Shareholder of EKIMAS Corp. Currently has a direct ownership of 5.3 Million shares of ASNB, which is worth approximately $0. The most recent transaction as insider was on Nov 12, 2024, when has been sold 4,030,903 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
5.3M
0%
3M change
n/a
12M change
Total Value Held
$0
TAA
Therapeutics Ap S Alteral
> 10% Shareholder
Klampenborg, G7